Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman (Q35570815)

8 August 2017

1 reference

title

Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman (English)

1 reference

8 August 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584824

26 March 2024

1 reference

10.1023/A:1026065122854

https://api.crossref.org/works/10.1023/A:1026065122854

26 March 2024

1

Dennis J Selkoe

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14584824

26 March 2024

publication date

1 November 2003

1 reference

8 August 2017

Neurochemical Research

1 reference

8 August 2017

28

1 reference

8 August 2017

11

1 reference

8 August 2017

1705-1713

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1026065122854

8 August 2017

0 references

cites work

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

12 December 2020

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

1 reference

12 December 2020

Identification of signal peptide peptidase, a presenilin-type aspartic protease

1 reference

12 December 2020

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

1 reference

12 December 2020

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

1 reference

12 December 2020

Correlations of synaptic and pathological markers with cognition of the elderly

1 reference

12 December 2020

A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

1 reference

12 December 2020

Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease

1 reference

12 December 2020

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

12 December 2020

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

12 December 2020

Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme

1 reference

12 December 2020

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

12 December 2020

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

12 December 2020

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1

1 reference

12 December 2020

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

1 reference

12 December 2020

Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier

1 reference

12 December 2020

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.

1 reference

12 December 2020

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

12 December 2020

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

12 December 2020

Alzheimer's disease is a synaptic failure

1 reference

12 December 2020

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

1 reference

12 December 2020

The brain's microenvironment, early functional loss, and the conversion to Alzheimer's disease

1 reference

12 December 2020

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

12 December 2020

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

1 reference

12 December 2020

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

12 December 2020

Evidence for genetic linkage of Alzheimer's disease to chromosome 10q

1 reference

12 December 2020

Amyloid beta protein enhances the survival of hippocampal neurons in vitro

1 reference

12 December 2020

A mathematical model of the impact of novel treatments on the A beta burden in the Alzheimer's brain, CSF and plasma

1 reference

12 December 2020

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

1 reference

12 December 2020

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

1 reference

12 December 2020

Clearing the brain's amyloid cobwebs

1 reference

12 December 2020

Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme

1 reference

12 December 2020

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity

1 reference

12 December 2020

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

1 reference

12 December 2020

Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.

1 reference

12 December 2020

Metabolic regulation of brain Abeta by neprilysin.

1 reference

12 December 2020

Inflammation and Alzheimer's disease pathogenesis

1 reference

12 December 2020

Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier

1 reference

12 December 2020

Alzheimer's disease and Abeta toxicity: from top to bottom

1 reference

12 December 2020

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

1 reference

12 December 2020

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

12 December 2020

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

1 reference

12 December 2020

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

12 December 2020

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

12 December 2020

γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2

1 reference

12 December 2020

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

12 December 2020

Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins

1 reference

12 December 2020

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

12 December 2020

The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain

1 reference

12 December 2020

Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.

1 reference

12 December 2020

Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain.

1 reference

12 December 2020

Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026065122854

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference